1. Home
  2.  |  
  4.  |  
  5. Corporate Current Affairs
  6.  |  
  7. Corporate Charge | Discharge

Corporate Charge | Discharge

COVID-19 Vaccine: Sanofi, GSK receives approval for Phase 3 trials in India

Jul 8, 2021
Sanofi and GSK announced that they have received the approval for the Phase 3 clinical study of their adjuvanted recombinant-protein COVID-19 vaccine candidate in India. Read all you need to know.

Register to get FREE updates

  • All Fields Mandatory
  • (Ex:9123456789)
  • Please Select Your Interest
  • Please specify

  • ajax-loader
  • A verifcation code has been sent to
    your mobile number

    Please enter the verification code below

Get App